Victory Capital Management Inc. reduced its position in MetLife, Inc. (NYSE:MET - Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 472,554 shares of the financial services provider's stock after selling 18,749 shares during the quarter. Victory Capital Management Inc. owned approximately 0.07% of MetLife worth $38,976,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the business. Carmichael Hill & Associates Inc. raised its holdings in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after acquiring an additional 186 shares in the last quarter. Wolff Wiese Magana LLC grew its stake in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Fortitude Family Office LLC increased its holdings in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after buying an additional 266 shares during the last quarter. Bank & Trust Co purchased a new position in MetLife in the second quarter valued at $39,000. Finally, Crewe Advisors LLC lifted its holdings in MetLife by 602.5% during the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider's stock worth $39,000 after buying an additional 482 shares during the last quarter. Institutional investors and hedge funds own 89.81% of the company's stock.
MetLife Price Performance
Shares of NYSE:MET opened at $83.33 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a 50-day simple moving average of $81.60 and a 200 day simple moving average of $75.56. MetLife, Inc. has a fifty-two week low of $61.61 and a fifty-two week high of $86.94. The company has a market cap of $57.70 billion, a PE ratio of 16.80, a P/E/G ratio of 0.74 and a beta of 1.05.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.62%. MetLife's dividend payout ratio is presently 43.95%.
Wall Street Analysts Forecast Growth
MET has been the topic of a number of recent analyst reports. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. StockNews.com raised shares of MetLife from a "hold" rating to a "buy" rating in a report on Tuesday. Bank of America lowered their target price on shares of MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Citigroup lifted their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a "buy" rating in a research note on Tuesday, July 23rd. Finally, Piper Sandler raised their price objective on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Fourteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $88.46.
View Our Latest Stock Report on MET
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.